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REGULAR ARTICLE
Robust adaptive immune response against Babesia microti infection
marked by low parasitemia in a murine model of sickle cell disease
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Key Points
•B microti infection in-
duces a robust adap-
tive immune response
in WT mice with co-
ordinated development
of GC reaction and
Ag-specific Abs.
• Sickle mice develop
low parasitemia, but
elicit a strong adaptive
immune response
despite a disorganized
splenic architecture
preinfection.
The intraerythrocytic parasite Babesia microti is the number 1 cause of transfusion-
transmitted infection and can induce serious, often life-threatening complications in
immunocompromised individuals including transfusion-dependent patients with sickle cell
disease (SCD). Despite the existence of strong long-lasting immunological protection against
a second infection in mouse models, little is known about the cell types or the kinetics of
protective adaptive immunity mounted following Babesia infection, especially in infection-
prone SCD that are thought to have an impaired immune system. Here, we show, using a
mouse B microti infection model, that infected wild-type (WT) mice mount a very strong
adaptive immune response, characterized by (1) coordinated induction of a robust
germinal center (GC) reaction; (2) development of follicular helper T (TFH) cells that comprise
;30% of splenic CD41 T cells at peak expansion by 10 days postinfection; and (3) high levels
of effector T-cell cytokines, including interleukin 21 and interferon g, with an increase in the
secretion of antigen (Ag)-specific antibodies (Abs). Strikingly, the Townes SCD mouse model
had significantly lower levels of parasitemia. Despite a highly disorganized splenic
architecture before infection, these mice elicited a surprisingly robust adaptive immune
response (including comparable levels of GC B cells, TFH cells, and effector cytokines
as control and sickle trait mice), but higher immunoglobulin G responses against
2 Babesia-specific proteins, which may contain potential immunogenic epitopes. Together,
these studies establish the robust emergence of adaptive immunity to Babesia even in
immunologically compromised SCD mice. Identification of potentially immunogenic epitopes
has implications to identify long-term carriers, and aid Ag-specific vaccine development.
Introduction
Human babesiosis is caused by the protozoan parasite Babesia microti, which invades and multiplies within
human red blood cells (RBCs). Infections vary greatly in their presentation depending on age and immune
competency of the host. Severe symptoms present in neonates,1-4 or in older adults, possibly due to
depressed cellular immunity5-7 and in the immunocompromised of any age, particularly asplenic individuals.8-14
Mild disease caused byBmicroti usually presents with intermittent fever with general malaise and weakness.15
In patients who were hospitalized with severe B microti infection, death occurred in ;10% of cases.16,17
B microti can be transmitted through blood transfusions, and remains the foremost infectious risk to the
US blood supply18-20 for which a Food and Drug Administration (FDA)–licensed test is still unavailable for
Submitted 25 September 2018; accepted 8 November 2018. DOI 10.1182/
bloodadvances.2018026468.
*W.Y. and W.B. contributed equally to this study.
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The full-text version of this article contains a data supplement.
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donation screening, with tests under investigational new drug not
performing optimally according to available data.21 Most blood
centers still rely on a blood donor questionnaire to self-identify any
previous history of babesiosis.20
Mechanisms underlying Babesia infection and host immune
response remain poorly understood. There are no studies to date
on the nature of the immune response in individuals infected with
B microti, with most available data coming from the parasitized
mouse models. The primary B microti infection, which is generally
self-limiting and nonlethal, generates a strong protection against
a subsequent infection,22 and can be passively transferred to
recipient mice by the transfer of splenocytes.23,24
Macrophages in innate immunity are critical for the clearance of
Babesia-infected RBCs as well as for driving resistance to
infection.25 In addition, T-cell–mediated immunity has been shown
to protect against B microti infection,22,26-31 although the exact
mechanism of the protection against a subsequent infection
remains unknown.22,26 In addition, B cells appear to be involved
in the clearance of Babesia, although in 1 study, it was deemed
that they had a minimal role in the control of acute parasemitia.26
Furthermore, various immunoregulatory cells have been implicated
in the immune response to Babesia.24,32 However, there are no
data regarding the contribution of adaptive immune cell compart-
ments during B microti infection. For example, little is known about
the kinetics of the induction of germinal center (GC) reaction, which
is critical for the development of B-cell responses and the
generation of plasma cells secreting high-affinity antibodies and
memory B cells.33-37 Nor is much known about the role of T follicular
helper (TFH) cells, which promote humoral immunity by providing
help to B cells and facilitating the selection of plasma and memory
cells33,38,39 in the adaptive response to B microti infection and
parasite clearance. Understanding the kinetics of adaptive immunity
against Babesia infection can help determine the pathogenesis of
babesiosis and account for persistent infection.26
Patients with sickle cell disease (SCD) require transfusions, which
dramatically increases their risk of transfusion-transmitted infections40;
however, little is known about B microti pathogenesis in human SCD
that results in disease exacerbation.13 An altered baseline immune
function in mice SCD confounded by impaired splenic function
may underlie exacerbated infections,41 as demonstrated by either
a hyporesponsive immune response or a hyperresponsive immune
response, depending on the types of antigens to which they have
been exposed.42 For example, whereas vaccination against both
Streptococcus pneumoniae and the influenza A virus produces
low titers of antigen-specific immunoglobulin G (IgG) and IgM43-45
and defects in viral clearance likely ascribed to decreased levels of
interferon g (IFNg) following influenza challenge in SCD mice,46
experimental asthma induces an exaggerated immune response,
as shown by increased antigen-specific IgE production.47-49 The
observation that sickle trait, heterozygous for hemoglobin S (HbS),
confers protection against malarial infection, whereas homozygous
HbS is associated with increased morbidity and mortality in both
humans and mice,50-55 is suggestive of impaired immunity in SCD.
However, there exists limited knowledge on immune functions in the
context of SCD, especially adaptive immunity.
In this study, we investigated the kinetics of adaptive immune
response to acute Babesia infection in mice to determine the extent
to which adaptive immunity contributes to babesiosis and whether
an impaired immune response in SCD would result in lethal
outcomes following B microti infection.
Material and methods
Mice
C57BL/6J (000664), transgenic SCD HbSS-Townes mice, and
HbAS-Townes mice, were purchased from The Jackson Laboratory
(Bar Harbor, ME). The HbSS-Townes mice (referred to as SS;
homozygous for bS) were created by knocking-in human a and bS
globins into the locus of murine a and b globins, leading to the
expression of only human globins.56 HbAS-Townes mice (referred to
as AS) have human a globin but are heterozygous for human bA and
bS globins. The HbAA-Townes control mice (referred to as AA) were
created by replacing bSwith bA and obtained by breeding the HbAS-
Townes mice. Both male and female mice, 9 to 12 weeks old, were
used for this study; animals were housed in microisolator cages in a
special pathogen-free facility. All animal studies were approved by the
New York Blood Center’s Animal Care and Use Committee.
Parasite infections and detection
The B microti (Franca) Reichenowi Peabody strain was obtained
from ATCC (Manassas, VA). Mice were infected via intraperitoneal
injection with 107 to 108 B microti–parasitized RBCs. Parasitemia
was determined using standard methods for collecting a drop of
anticoagulated blood from the tail vein and using this blood to
perform Giemsa staining and flow cytometry.
Light microscopy. Blood smears were fixed with methanol
and stained with 20% Giemsa (Sigma-Aldrich, St. Louis, MO) for
the morphological analysis of parasites and for evaluation of
parasitemia. A minimum of 2000 cells was counted for parasitemia
measurement or scanned for assessment of changes in morphology
using a Nikon Eclipse E 600 microscope.
Flow cytometry. The size of the in vivo B microti–infected
RBC population was measured by flow cytometry, by performing
a novel dual-color staining protocol, developed in our laboratory,
modifying a protocol previously designed for Babesia divergens.57
Mouse erythrocytes were identified by allophycocyanin (APC)
rat anti-mouse TER-119 (BD Pharmingen). Infected RBCs
were identified by staining parasite DNA using Hoescht 33342
(29-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2, 59-bi-1H-benzimidazole
trihydrochloride trihydrate) (Thermo Fisher Scientific). As all RBCs
lack a nucleus, RBCs with a positive signal for DNA represent
infected host cells bearing parasites. To avoid inaccurate parasitemia
determinations because of the presence of RNA in reticulocytes, the
preferential binding of Hoechst to A-T regions of DNA was exploited.
APC–TER-119 antibody was used at 0.005 mM and Hoechst at
0.1 mM final concentrations at a concentration of 1 3 107 cells per
milliliter. Samples were analyzed on a LSR Fortessa SORP analyzer
(BD Biosciences), equipped with a 355-nm UV laser for Hoechst
detection (361/486 nm) and a 640-nm red laser for APC–TER-119
detection (650/60 nm BP). The forward scatter threshold was set on
5000, and 10 000 total events were acquired at low flow rate.
FACSDiva software (version 6.2; BD Biosciences) was used for data
analysis. All parameters were processed using log scaling.
Flow cytometry and antibodies for immune studies
Various tissues including spleens and lymph nodes along with
peripheral blood were collected from mice on the indicated days
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following B microti infection, and the spleens were weighed. Single-
cell suspensions were prepared by gently meshing the spleens
and lymph nodes in RPMI 1640 medium containing 10% fetal
bovine serum. The cells were incubated with anti-CD16/32
(FRC-4G8) at 4°C for 15 minutes in phosphate-buffered saline
(PBS) containing 0.5% bovine serum albumin (BSA). For flow
cytometry, lymphocytes (1 3 106 cells) were incubated with
fluorescence-labeled or biotinylated monoclonal antibodies (mAbs)
followed by fluorescent streptavidin, and analyzed as previously
described.58 APC-labeled anti-Foxp3 (FJK-16s) mAbs, phycoerythrin
(PE)/Cy7-labeled anti-IgM (II/41) mAb, PE-labeled anti-IgD (11-26c)
mAb, fluorescein isothiocyanate (FITC)-labeled anti–programmed
death 1 (PD-1; J43) mAb, anti-CD16/CD32 (FRC-4G8) mAb,
peridinin chlorophyll protein (PerCP)/Cy5.5-labeled anti-IFNg (XMG1.2)
mAb, and APC-labeled anti–interleukin 4 (IL-4; 11B11) mAb were
purchased from Thermo Fisher.
Alexa F700 or Pacific Blue–labeled anti-CD4 (RM4-5), PerCP/
Cy5.5-labeled anti-CD278 (inducible costimulator [ICOS]; C398.4A),
Alexa F700–labeled anti-CD44 (IM7), Pacific Blue–labeled anti-
CD45R/B220 (RA3-6B2), and PerCP/Cy5.5-labeled streptavi-
din were purchased from BioLegend. Biotinylated anti-CD95
(Fas; Jo2), FITC-labeled anti–T- and B-cell activation antigen
(GL7), APC-labeled anti-CD138 (281-2) mAb, biotinylated
anti-CXCR5 (2G8) mAb, PE or PE-CF594–labeled anti-Bcl-6
(K112-91) mAb, and PE-Cy7–labeled streptavidin were purchased
fromBDBiosciences. Recombinant mouse IL-21R Fc chimera protein
was purchased from R&D Systems. R-Phycoerythrin AffiniPure
F(ab9)2 fragment goat anti-human IgG, Fcg fragment-specific,
antibody was purchased from Jackson ImmunoResearch Labora-
tories. For the staining of regulatory T cells (Tregs), APC anti-mouse
Foxp3 (Thermo Fisher) was intracellularly stained according to the
manufacturer’s instructions. For the intracellular staining of IL-21,
splenocytes were stimulated with phorbol myristate acetate (50 ng/mL)
and ionomycin (1 mM; EMD) for 4 hours in the presence of protein
transporter inhibitor brefeldin A (1 mg/mL; BD Biosciences). After
surface staining, the cells were fixed with Cytofix/Cytoperm buffer
(BD Biosciences) for 30 minutes and incubated with recombinant
mouse IL-21R Fc chimera protein for 30 minutes on ice, followed by
the staining with a PE-labeled affinity purified F(ab9)2 fragment of
goat anti-human Fcg antibody. Flow cytometric data were analyzed
with FlowJo software (TreeStar).
Immunofluorescence microscopy
Immunofluorescence staining was performed as reported previously.58
Briefly, spleens of micewere frozen after embedding inOCT compound
(Tissue-Tek; Sakura). Frozen blocks were cut into 6 mm in thickness
with a microtome at 220°C and dried .2 hours at room temperature.
Sections were fixed in cold acetone for 15 minutes and kept at280°C.
Sections were blocked with 3% BSA (serum-free; Jackson Immuno-
Research Laboratories) in PBS for 20 minutes. Cryosections were
incubated with primary antibodies, PE-conjugated anti-IgD (11-26c.2a;
Thermo Fisher), APC-conjugated anti-CD3e (145-2C11; Thermo
Fisher), and FITC-conjugated peanut agglutinin (PNA; Vector
Laboratories) for staining of GCs. Images were captured using an
inverted LSM 780 laser-scanning confocal microscope (Zeiss).
Immunohistochemistry and H&E staining
Histology and immunohistochemistry slide preparation and in-
terpretation were performed at the Laboratory of Comparative
Pathology of Memorial Sloan Kettering Cancer Center, Weill
Cornell Medicine, and The Rockefeller University. Tissues were
fixed in 4% paraformaldehyde, processed routinely in alcohol and
xylene, embedded in paraffin, sectioned at 5-mm thickness, and
stained with hematoxylin-eosin (H&E). Immunohistochemistry (IHC)
staining for B220 and CD3 was performed on a Leica Bond RX
automated stainer (Leica Biosystems, Buffalo Grove, IL). Following
heat-induced epitope retrieval at pH 6.0 (B220) and 9.0 (CD3),
the primary antibody against B220 (BD Pharmigen 550286) and
CD3 (Abcam ab16669) was applied at a concentration of 1/200
and 1/100, respectively, followed by application of a polymer
detection system including secondary antibodies (Novocastra
Bond Polymer Refine Detection; Leica Biosystems), according to
the manufacturer’s instructions. The chromogen was 3,3 diamino-
benzidine tetrachloride, and sections were counterstained with
hematoxylin. Interpretation of H&E and IHC slides was performed by
a board-certified veterinary pathologist.
Luminex immunoassay
The concentrations of plasma antibody class/subclass in naive
and B microti–infected mice were measured using the Milliplex
Antibody Isotyping 7-Plex Mouse ProcartaPlex Panel 2 Immuno-
assay according to the manufacturer’s instructions, as previously
described.59 Briefly, the diluted mouse plasma (1/40 000) was incu-
bated with the antibody magnetic beads (IgG1, IgG2a, IgG2b, IgG3,
IgA, IgE, IgM) followed by antibody detection beads. The concentration
of 7 antibodies was calculated by plotting the expected concentration
of the standards against the mean fluorescence intensity generated
by each standard and the concentrations adjusted to account for
the dilution.
ELISA for parasite-specific immunoglobulins
B microti crude extract preparation and ELISA.
Following B microti infection, when the parasitemia was ;60%,
mice were scarified and RBCs used to prepare the crude lysate by
controlled lysis of the parasite-infected erythrocytes with 0.1%
saponin in 0.06 M NaCl, ultrasonication in the presence of enzyme
inhibitors, centrifugation at 4°C, and filtration on a 0.2-mm pore-size
filter (Millex). Protein concentrations were determined, and extracts
were frozen at 280°C in working aliquots.
Total B microti antigen (100 mL of 10 mg/mL) in 50 mM sodium
bicarbonate, pH 9.4, was used to coat enzyme-linked immunosor-
bent assay (ELISA) plates overnight at 4°C. Then, 200 mL of
blocking buffer (2% BSA in PBSwith 0.05% Tween-20) was added
to each well and the plates incubated for 1 hour at 37°C. Serum
samples were serially diluted from 1/100 to 1/100 000 in a dilution
buffer (1% BSA in PBS with 0.05% Tween-20) and 100 mL of
diluted serum was distributed into each well (each sample tested in
triplicate). Polyclonal anti-mouse IgG (1/5000; GE Healthcare) or
anti-mouse IgAGM (1/2000; KPL) conjugated to peroxidase was
added. Bound peroxidase was detected with sureblue substrate
(KPL) 20 minutes (100 mL) and the reaction was stopped by addition
of 2 M H2SO4 (50 mL per well). Between each incubation phase, the
ELISA plates were washed extensively with PBS–0.05% Tween-20.
The optical density (OD) at 450 nm was read in a Bio-Rad microplate
reader.
Library ELISA. Biotinylated B microti recombinant proteins
produced using a mammalian expression system were immobilized
in individual wells of streptavidin-coated microtiter plates as described
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in detail previously.60 Briefly, 26Bmicroti genes that are predicted to
encode surface-displayed and secreted proteins were expressed by
transient transfection in suspension-grown HEK293E. 6-His–tagged
proteins were purified from spent tissue culture supernatant. Protein
levels were quantified by ELISA after immobilizing dilutions of the
biotinylated CD4-tagged protein in individual wells of streptavidin-
coated microtiter plates and using the mouse anti-rat CD4 mono-
clonal antibody (OX68) as a detection antibody and an anti-mouse
alkaline phosphatase conjugate as a secondary antibody. To quantify
elicited mouse antibody titers, proteins were immobilized directly on
streptavidin-coated plates as above (using the mouse anti-rat CD4
monoclonal antibody). Sera was diluted 1/2000 in 2% (wt/vol)
BSA-PBS, and total mouse IgG binding was detected using anti-
mouse alkaline phosphatase–conjugated secondary antibody.
Statistical analysis
Statistical analysis was performed with Graphpad Prism 7 and
statistical significance was analyzed using unpaired 2-tailed
Student t tests. Statistical details of experiments are described in
the figure legends. P , .05 was considered significant. *P , .05,
**P , .01, ***P , .001, and ****P , .0001.
Results
Kinetics of B microti infection in C57BL/6J mice
Intraperitoneal B microti infection with 107 to 108 parasitized RBCs
in multiple experiments resulted in robust infection in C57BL/6J mice
as detected by flow cytometry as well as Giemsa-stained blood
smears (supplemental Figure 1A-E). However, there was 100% survival
in themice following infection (data not shown). Consistent with previous
data,26 the levels of B microti parasitemia exponentially increased
between day 3 and day 7, reaching maximal levels at day 7
postinfection with as high as 48% 6 1% of erythrocytes being
infected, followed by parasite clearance (,1%) by day 21 post-
infection (Figure 1A). IV parasite infections produced similar kinetics
of parasitemia, albeit with faster initial establishment of infection (data
not shown). Erythrocyte numbers and hemoglobin content were
significantly reduced (from 9.66 0.23 106/mL and 13.26 0.7 g/dL
to 4.1 6 0.3 3 106/mL and 5.7 6 0.5 g/dL, respectively) by day 7
postinfection and began to recover from day 21 onwards upon
clearance of parasites and returning to an almost normal range
(8.7 6 0.2 3 106/mL and 12.9 6 0.3 g/dL, respectively) at day 38
postinfection (Figure 1B-C). In contrast, reticulocyte counts steadily
increased reaching 60% by day 10 postinfection but were on a
decline by day 21 postinfection (Figure 1D). Infection induced
splenomegaly as previously reported61,62 (supplemental Figure 2A)
with an approximately ninefold increase in spleen weights
(Figure 1E), and 4.5-fold increase in total splenocyte numbers by
day 14 postinfection (Figure 1F), which interestingly lagged behind
peak parasitemia on day 7.
B microti infection induces a robust GC reaction, and
a significant expansion of TFH cells
To uncover a potential protection mechanism against B microti
infection in the spleen, we investigated the adaptive immune
response in the spleens of B microti–infected C57BL/6J mice.
During GC formation, GC B cells downregulate the surface
expression of IgD, whereas they increase the surface expression of
GL7 and Fas.35,36,63,64 By contrast, plasma cells downregulate the
surface expression of B220, whereas they express high levels of
CD138.65-68 GC B cells (GL71Fas1B2201) were strongly induced
upon B microti infection beginning on day 7 at 4.2% 6 0.7% as
compared with,1.5% before infection and reaching 12.1%6 1.2%
by day 14 after which point there was a trend toward a decline,
although, surprisingly, the levels remained high (10.3%6 0.5%) even
at day 21 postinfection when parasitemia is resolved (Figure 1G-H
top panels), consistent with a robust B-cell immune response that
continued to increase even after peak parasitemia on day 7.
Interestingly, we observed very high percentages of splenic plasma
cells (CD1381B220low) ;2.8% 6 0.3% on day 7 postinfection,
which is most likely induced primarily by T-independent immune
responses. The percentage of plasma cells was maintained at high
.1% until day 21 postinfection (Figure 1G-H bottom panels).
We also examined whether the TFH compartment, identified as
CXCR51PD11CD41 by flow cytometry,58 is impacted during
B microti infection. We detected a significant development of TFH
cells upon parasite infection, with 31% 6 2% of CD41 T cells
becoming TFH cells on day 10 and remaining high (33% 6 2%)
through day 14 postinfection (Figure 1G,I, as compared with
,3% before infection). The kinetics of TFH cell development
paralleled that of GC B cells, suggesting a well-coordinated
induction of adaptive immune response against B microti in-
fection (Figure 1D-G).
T-cell effector cytokines and plasma
immunoglobulins following B microti infection
To evaluate T-cell effector function during B microti infection, we
determined the levels of cytokines over the course of infection,
focusing on IL21, a critical cytokine for the GC formation, and TFH
and B-cell differentiation and immunoglobulin class switching38,69-75
and IFNg, which is implicated in the pathophysiological function of
TFH cells and protection against Babesia
32,76 as well as immuno-
globulin switching.74,77 We found a significant induction of IL21 as
well as IFNg with ;8% and 7% of CD41 T cells, respectively, in
splenic CD441 effector CD41 T cells as early as day 5 postinfection
(Figure 2A).
We next measured the titers of class-switched total immunoglob-
ulins by Luminex assay to examine the humoral immune responses
during Babesia infection. Consistent with expression of effector
cytokines involved in class switching, we found a significant
increase in the plasma levels of all isotypes tested including IgM
(@1.2 mg/mL), IgG1 (@15 mg/mL), IgG2b (@170 mg/mL), IgG2c
(@0.6 mg/mL), IgG3 (@1.5 mg/mL), IgA (@50 mg/mL), and IgE
(@45 mg/mL) antibodies by day 10, followed by a decrease on
day 38 postinfection (Figure 2B-C). In addition, using whole-cell
extracts from parasitized RBCs, we detected a gradual increase of
Babesia-specific IgM antibody levels beginning at day 3 (OD@ 0.2)
until day 38 (OD @ 0.5), when the levels started declining
(Figure 2D left panel). Interestingly, the levels of Babesia-specific
IgG antibodies were continually increasing at day 38 (OD @ 0.7)
postinfection, the last point we measured (Figure 2D right panel),
suggestive of an active ongoing adaptive immune response.20
Townes mice, a murine model of human SCD, have
low levels of parasitemia followingBmicroti infection
We next evaluated the adaptive immune response of the Townes
SCD mouse model56 following infection with B microti. Berkeley
SCD mice have been reported to have severely disrupted splenic
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Figure 1. Kinetics of adaptive immune response following B microti infection in C57BL/6 mice. Groups of C57BL/6 mice were infected with 1 3 107 to 1 3 108
B microti–parasitized RBCs intraperitoneally and a representative experiment is shown. (A) The frequency of peripheral blood erythrocytes infected with B microti in total number
of RBCs over time. (B-D) Peripheral blood on the indicated days following B microti infection were analyzed using an Advia 120 hematology system for absolute numbers of
RBCs (B), hemoglobin (Hgb) content (C), and reticulocyte percentages (D) (n 5 3-10). (E-F) The spleen weights (E) and the number of splenocytes (F) before and after B
microti infection (n 5 3-12). (G) Representative flow cytometry (FACS) plots for GL7 and FAS gated on B2201 cells for the identification of splenic GC B cells (top panel) or
B220 and CD138 for the identification of plasma cells (bottom panel) before infection (D0) and after infection on days 3, 10, and 14 (D3, D10, and D14). (H) Quantification of
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architecture, leading to impaired immunity against pathogens.41 As
controls, we used AA mice that express 2 normal (A) copies, or trait
AS mice expressing 1 normal (A) and 1 sickle (S) human Hb gene,
respectively. Based on multiple experiments, we found that AA and
ASmice exhibited similar levels of parasitemia, but surprisingly SSmice
consistently presented with at least fourfold to fivefold lower levels of
parasitemia (see example Figure 3A, approximating 20%parasitemia at
peak levels in AA and AS mice but only 4% to 5% in SS mice). All
parasite forms were visible in the 3 strains and looked identical
morphologically (supplemental Figure 1E). All mice, irrespective of
genotype, were eventually able to clear their infections.
Spleen weights of AA and AS mice gradually increased @ threefold
following B microti infection, whereas that of SS mice, despite the
high basal levels (@ sixfold increased spleen weights compared
with those of AA and AS), were still marginally enlarged after
infection (Figure 3B; supplemental Figure 2B).
B microti infection induces a vigorous GC reaction in
Townes mice despite low levels of parasitemia
Given the low levels of parasitemia compared with AA and AS mice,
as well as an eventual resolution of B microti infection even in SS
mice, we examined the adaptive immunity in the spleens of SS mice.
As expected from higher frequencies of cells in myeloid lineages in
naive SS mice, we observed low levels of overall frequencies of B
and T cells in the spleens of uninfected SS mice (supplemental
Figure 3A-B). Although the frequencies of B cells remained low over
the course ofBabesia infection, the frequencies of T cells increased
to a level similar to those of AA and AS mice at day 10 postinfection
(supplemental Figure 3A-B). Despite lower levels of parasitemia
(Figure 3A), SS mice surprisingly mounted a very strong adaptive
immune response following B microti infection, as shown by high
percentages of GC B cells on days 5 and 10 (.12%) postinfection
as compared with ,1.5% before infection, and more importantly
similar to levels induced in AA or AS mice (Figure 3C-D; P . .1). A
similar pattern of GC reaction in all 3 strains of mice was detected
even on day 17 (supplemental Figure 4A) when parasitemia had
almost cleared (supplemental Figure 2B-C) after which point a
decrease in GC B-cell percentages was finally apparent (supple-
mental Figure 4A day 21). Interestingly, we detected a similar trend
of immune responses in the lymph nodes from all 3 strains of mice
postinfection, suggesting that SS mice induce overall similar levels
of GC reaction following B microti infection (supplemental
Figure 4B). As with GC B cells, we observed high percentages of
splenic plasma cells (CD1381B220low) in SS mice at days 5 and
10 postinfection (1.7% 6 0.2% and 1.5% 6 0.2%, respectively)
similar to those of AA or AS mice (Figure 3E-F) with a detectable
decline in percentages on day 21 postinfection (data not shown).
To gain a better insight into the enhanced adaptive immune
response in the spleens of SS mice, we next evaluated the size and
distribution of splenic GC B cells by immunofluorescence imaging
(Figure 4). As expected, spleens from naive AA or SS mice have
very small to no GCs (Figure 4 PNA shown in green). Notably,
spleens from naive SS mice showed very small follicles identified by
IgD staining (Figure 4A shown in red). Furthermore, we detected
indistinct boundaries between the B-cell zone and T-cell zone
identified by IgD (in red) and CD3 staining (in blue, white arrows),
respectively, in the spleens from naive SS mice compared with
those of AA (Figure 4A) or AS mice (data not shown). Remarkably,
following Babesia infection, spleens from SS mice formed distinct,
well-organized GCs similar to those of AA mice (Figure 4B).
To evaluate whether spleens from SS mice have a unique splenic
architecture following B microti infection enabling them to form
such well-developed GCs, we performed IHC staining for B220
and CD3. Similar to the Berkeley SCD mouse model,42 SS Townes
mice showed overtly disorganized splenic architecture in the naive
state (Figure 5A). Specifically, we detected big follicles with a
distinct T/B boundary in the spleens from AA and C57BL/6 mice
(Figure 5A). However, consistent with immunofluorescence staining
with IgD, spleens from naive SS mice have very small, indistinct
follicles identified by B220 (blue arrows), which is found in
overlapping regions with T cells identified by CD3 (red arrows)
(Figure 5A). CD31 T cells were dispersed around the periarteriolar
lymphatic sheathes, making an indistinct T/B boundary in SS mice,
whereas they were densely populated around the well-developed
periarteriolar lymphatic sheathes in AA (Figure 5A) and AS mice
(data not shown). Interestingly, we observed marked changes in
splenic architecture following B microti infection, but, surprisingly,
the overall organization of the white pulp of the spleens was
relatively comparable in all 3 strains postinfection with significantly
enlarged follicles in all mice at day 10 (Figure 5B). This was
accompanied by the development of distinct GCs that were
relatively well-organized and comparable in size in all 3 strains
(Figures 4B and 5B, and data not shown) with loosening of a clear
T-cell zone boundary in both AA and SS mice.
TFH cell development, T effector cytokines, and Tregs
in B microti–infected Townes mice
In agreement with a strong GC reaction, we detected high
frequencies of CXCR51PD11CD41 TFH cells in all 3 strains (on
day 5 with 9% 6 2%, 11% 6 2%, and 12% 6 1% in AA, AS, and
SS, respectively, as compared with ,6% before infection in all strains),
which increased to 39% 6 4%, 40% 6 3%, and 38% 6 1% in AA,
AS, and SS, respectively, on day 10 postinfection (Figure 6A-B).
Interestingly, we observed slightly lower expression of ICOS, a critical
costimulatory molecule in the generation of class-switched anti-
bodies,78 in TFH cells at the beginning of the immune response in SS
mice compared with that of AA and AS mice, suggesting a potential
qualitative difference in SS TFH cells (supplemental Figure 3C).
However, this difference was eliminated by day 10 postinfection
(supplemental Figure 3C). Even when parasitemia began to clear on
day 17 (supplemental Figure 2C), TFH cell frequencies were high
and remained comparable in AA, AS, and SS mice (supplemental
Figure 4C). As with GC B cells, overall TFH cell frequencies began to
decrease after day 17 postinfection (supplemental Figure 4C). We
also found a similar increase in the frequency of TFH cells in the
lymph nodes in all 3 strains (supplemental Figure 4D).
Figure 1. (continued) GC B cells (top panel) and plasma cells (bottom panel) (n 5 3-10). (I-J) Flow cytometric analysis of TFH cells in C57BL6 mice. (I) Representative
FACS plots for CXCR5 and PD1 expression gated on splenic CD41 T cells. (J) Quantification of TFH cells (CD4
1CXCR5hiPD1hi) (n 5 3-10). Each symbol represents
data from an individual mouse. Error bars indicate the mean 6 standard error of the mean (SEM). *P , .05; **P , .01; ***P , .001; ****P , .0001 by unpaired 2-tailed
Student t test.
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In line with a strong adaptive immune response following B microti
infection, we detected a robust increase of IFNg1 T cells in the
spleens from all 3 strains of mice with 13% 6 1%,16% 6 3%,
18% 6 1% of CD441 memory CD41 T cells in AA, AS, and SS,
respectively, on day 5 postinfection and comparable frequencies at
day 10 (Figure 6C-D), suggesting a similar effector function of
T cells in SS mice. We also found a similar trend in the expression
of IL21 in all 3 mouse strains (Figure 6E-F). These data suggest that
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Figure 2. CD41 T cells expressing cytokines and the
kinetics of plasma immunoglobulin levels following
B microti infection in C57BL6 mice. (A) Representative
FACS plots for CD44 and IL21 (top) or IFNg (bottom)
expression gated on CD41 T cells in the spleens from mice
before (D0) and after B microti infection on days 5 and 10.
(B-C) Plasma immunoglobulin levels of IgM (B), IgG1, IgG2b,
IgG2c, IgG3, IgA, and IgE (C) on days indicated following
Babesia infection. The concentrations of each immunoglobulin
isotype were determined by Luminex assay with appropriate
immunoglobulin standards. (D) The kinetics of B microti–
specific antibody responses in C57BL/6 mice following in-
fection. Plasma was collected from mice on the days indicated
and the levels of IgM and IgG antibodies were determined by
ELISA using crude cell lysate of RBCs infected with B microti.
Each symbol represents data from an individual mouse.
Error bars indicate the mean 6 SEM. *P , .05; **P , .01;
***P , .001; ****P , .0001 by unpaired 2-tailed Student
t test.
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Figure 3. Kinetics of adaptive B-cell immune response following B microti infection in Townes SS and control mice. Groups of Townes SS mice along with control
AA and AS mice were infected with 1 3 107 to 1 3 108 B microti–parasitized RBCs intraperitoneally and a representative experiment is shown. (A) The frequency of peripheral blood
erythrocytes infected with B microti in total number of RBCs. (B) The spleen weights of AA, AS, SS mice before and after infection. (C) Representative FACS plots for GL7 and FAS gated
on B2201 cells for the identification of GC B cells in the spleens from AA, AS, and SS mice. (D) Quantification of GC B cells in the spleens from AA, AS, and SS mice on days indicated before
and following infection. (E) Representative FACS plots for B220 and CD138 for the identification of plasma cells. (F) Quantification of plasma cells in the spleens from AA, AS, and SS mice. Each
symbol represents data from an individual mouse. Error bars indicate the mean 6 SEM. **P , .01; ***P , .001; ****P , .0001 by unpaired 2-tailed Student t test. ns, not significant.
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Figure 4. Immunofluorescence analysis of splenic T- and B-cell zones of Townes SS and control mice before and following B microti infection. Representative
immunofluorescence images of splenic sections from uninfected (A) and B microti–infected (B) Townes SS and control AA mice (n 5 2-3 mice) stained for PNA (a GC
marker, using FITC-conjugated PNA, in green), IgD (a B-cell marker, using PE-conjugated anti-IgD, red), and CD3 (a T-cell marker, using APC-conjugated anti-CD3e, blue).
Although there is a clear T-cell (blue)/B-cell (red) boundary in the spleens from naive AA mice, T cells are located independently of B-cell follicle, without a clear boundary in
the spleens from naive SS mice. GCs marked by PNA in green are formed similarly in both AA and SS mice following Babesia infection. Green arrows indicate clusters of
PNA1 GC B cells (GCB); white arrows indicate CD31 T cells. Scale bars, 200 mm. FOB, follicular B cell.
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Figure 5. Analysis of splenic follicles of Townes SS and control mice before and following B microti infection. Representative immunohistochemical staining of
splenic follicles in Townes SS and control AA and C57BL/6 mice before (A) or after (B, on day 10) B microti infection. Splenic sections were stained for B220 (and detected
using horseradish peroxidase (HRP)–linker antibody conjugate with DAP as substrate, brown) and CD3 (and detected using HRP-linker antibody conjugate with DAP as
substrate, brown) (n 5 2-3 mice). T cells and follicular B cells (FOB) are localized in nonoverlapping areas in the spleens from naive, uninfected C57BL/6, and AA mice.
Spleens from naive, uninfected SS mice shows very small indistinct follicles. Following Babesia infection (B), large GCs are formed in the spleens from both AA and SS mice.
Red arrows indicate B2201 B-cell follicles; blue arrows indicate CD31 T cells. T-cell zone is marked in blue. Scale bars, 200 mm.
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Figure 6. Kinetics of T-cell immune response following B microti infection in Townes SS and control mice. (A-B) Flow cytometric analysis of TFH cells in Townes
SS and control AA and AS mice following B microti infection. (A) Representative FACS plots for CXCR5 and PD1 expression gated on splenic CD41 T cells. (B)
Quantification of TFH cells (CD4
1CXCR5hiPD1hi) (n 5 2-6). Combined data from 3 independent experiments. (C) Representative FACS plots for CD44 and IL21 expression
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T effector cells in SS mice have a similar effector function in
controlling the acute B microti infection during the earlier phase of
Babesia infection.
We hypothesized that the Tregs in SS mice may be altered causing
defects in regulating the function of T effector cells, which may
result in the expansion of T effector cells including TFH cells, leading
to an efficient adaptive immune response. However, we did not
detect any differences among the 3 different strains of mice
(supplemental Figure 4E), indicating that Treg cells in infected SS
mice are at least quantitatively similar to infected AA and AS mice.
Plasma immunoglobulins and Babesia-specific
antibody response in Townes mice
To evaluate whether there are altered immunoglobulins in the plasma
of infected SS mice, we first measured total immunoglobulin
levels in the plasma of infected mice over the course of Babesia
infection using the Luminex assay. We observed similar levels of
all of the immunoglobulins measured following Babesia infection
(IgG1 [@12 mg/mL], IgG2b [@300 mg/mL], IgG2c [@0.8 mg/mL],
IgA [@20 mg/mL], and IgE [@15 mg/mL]) except for the levels of
IgM on day 10 postinfection, which showed a twofold decrease in
SS mice (data not shown), consistent with the deficiency of marginal
zone B cells, known for IgM production, in SS mice and humans.79,80
These data indicate that overall levels of total switched immunoglob-
ulins are very similar in all 3 strains of B microti–infected mice.
We next considered the possibility that there may be a difference in
the Babesia-specific antibody repertoire enabling them to respond
differently against infection. We have previously identified immuno-
reactive extracellular parasite proteins from B microti against
humans andmice.60Using 26 such proteins (supplemental Table 1),
we observed 9 proteins that induced a strong antibody re-
sponse against B microti infection in C57BL/6 mice (supplemental
Figure 4). A similar pattern of reactivity was detected in AA, AS, and
SS mice toward the later part of the infection, around day 17
postinfection (Figure 7). However, Bm32 (a putative copper transport
protein) and, even more so, Bm34 (a sporozoite microneme protein),
respectively,81 were reproducibly found to elicit a significantly higher
antibody response in SSmice as compared with AA or ASmice (1.3-
to 1.4-fold and fourfold to ninefold, respectively; Figure 7B).
Discussion
In this study, we have investigated the immune response against
B microti infection with a special focus on a quantitative un-
derstanding of the kinetics of adaptive immune responses to
infection using murine models. We found that Babesia infection in
C57BL/6 mice induced a very strong adaptive immune response,
characterized by a robust GC reaction, and significant expansion of
TFH cells with as much as one-third of CD4
1 T cells becoming TFH
cells. By comparison, ,10% of CD41 T cells developed into TFH
cells following a conventional T-dependent antigen immunization
with alum-precipitated 4-hydroxy-3-nitrophenylacetyl-chicken gamma
globulin (data not shown). The kinetics of TFH cell development were
similar to that of GC B cells, suggesting a well-coordinated induction
of adaptive immune response against B microti infection. Although it
is not known whether these GCs harbor antigen-specific cells, the
GC/TFH response along with production of effector T-cell cytokines
IL-21 and IFNg, led to an increase in the secretion of antigen-specific
antibodies over time. Interestingly, we detected a delay in the kinetics
of the GC/TFH cell expansion compared with those of parasitemia. For
example, GC/TFH cells reached the peak on day 14 postinfection
following the peak of parasitemia on day 7 postinfection in C57BL/6
mice. A similarly strong GC/TFH cell response, but yet delayed, is also
observed after infection with Plasmodium chabaudi chabaudi in
mice.82 The significance of this exaggerated adaptive immune
response against Babesia and Plasmodium infection, however, is
currently not known. Our finding that B microti infection induces GC
B cells supports a role for B cells in control of Babesia infection and
parasite clearance, and is consistent with the reports of persistent
babesiosis in patients treated with B-cell–depleting rituximab.83,84 It is
also likely that TFH cells are equally important for controlling B microti
given that a crucial role of TFH cells in the clearance of RBC parasites
has been demonstrated in a lethal Plasmodium berghei ANKA
infection, where compromised TFH cell development resulted in an
impaired GC reaction leading to severe malaria.85
A striking finding of this study was that Babesia induced a very
robust adaptive immune response in SCD mice, despite very low
levels of parasitemia. The overall levels of adaptive immune
response, such as the proportion of GC B cells and TFH cells,
were very similar in control (AA and AS) and SS mice despite a
significant difference in the levels of parasitemia. This is surprising
considering that uninfected naive SSmice have massively disrupted
splenic architecture, which may inhibit the obligatory interactions
between B and T cells during GC reactions. We therefore had
expected to detect very low to no immune response against
B microti infection, causing the mice to develop severe babesiosis
and even death. Instead, we found that despite a disorganized
splenic architecture, the collaboration between T and B cells to
form GCs surprisingly does occur following B microti infection in
SCDmice. The formation of GCs and plasma cells independently of
the discrete T-/B-cell boundary has been reported in malarial
infection, suggesting that B cells can form fully functional GCs in
collaboration with the follicular dendritic cells in the absence of
distinct follicles.82 Remarkably, the marginal zone B cells that
facilitate antigen transport to follicular dendritic cells is also
significantly reduced in naive SS mice (data not shown) and yet
the immune response to Babesia is apparently intact. Interestingly,
the selective loss of IgM antibody secretion due to a loss of
IgMhiIgDlowCD271 “IgM memory B cells” residing in the marginal
zone was also observed in patients with SCD,79,80 suggesting that
marginal zone B cells may also be absent in human SCD. The
discrepancies of the kinetics between the levels of parasitemia and
the degrees of adaptive immunity in SSmice imply that there may be
an unknown immune pathway in the spleens of SS mice, which
enable them to induce an efficient adaptive immune response.
The observed heightened immune response against Babesia
infection in SCD can be explained by at least 2 premises. First,
SCD mice may have a stronger immune system against Babesia
infection than AA and AS mice. However, we did not find increased
Figure 6. (continued) gated on splenic CD41 T cells. (D) Quantification of IL211 cells in the spleens from AA, AS, and SS mice. (E) Representative FACS plots for CD44
and IFNg expression gated on splenic CD41 T cells. (F) Quantification of IFNg1 cells gated in the spleens from AA, AS, and SS mice. Each symbol represents data from an
individual mouse. Error bars indicate the mean 6 SEM. ***P , .001; by unpaired 2-tailed Student t test.
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percentages of the immune cells, including GC or TFH cells. Instead,
we have found that 2 of the Babesia-specific epitopes, Bm32 and,
even more robustly, Bm34, induced significantly higher Babesia-
specific IgG responses toward the later part of the infection in SS
mice as compared with AA or AS mice. Bm32 (BMN1-20) is a
59-kDa member of the immunodominant BMN family and has been
putatively identified as a copper transport protein analogous to
transporter proteins seen in Plasmodium and Theileria.86-88 Bm34
has been identified as a sporozoite microneme protein.81 It is a
96-kDa protein located in the apically situated micronemes of the
parasite. Interestingly, Bm34 contains a membrane attack complex
domain, which is known to be responsible for pore formation in
target membranes in a number of systems and could be used by
the parasite to porate the RBC membrane to facilitate invasion or
egress. However, no characterization of either Bm32 or Bm34
protein has been carried out yet and the effects of these epitopes in
response to Babesia infection, especially in adaptive immunity, are
currently not known. If these epitopes are critical factors among
various stages of Babesia infection, including the initial attachment,
penetration, and internalization into the RBC, then the increased
immune response in SCD mice against these 2 proteins would lead
to inhibition of the expansion of parasitemia despite no apparent
increase in the other parameters of adaptive immunity, including GC
B cells and TFH cells relative to AA and AS mice. As such, a detailed
study of these molecules relating to their role in pathogenesis may
provide clues as to why the SCD mice respond so strongly to these
antigens and whether this response plays a role in the resistance
to hosting the high parasite loads seen in the sickle trait (AS) and
wild-type (AA or C57BL/6) mice. Our findings of the differences of
antibody repertoire will be very useful in future studies, such as in
the search for immunoreactive antigens of Babesia, which can
improve a diagnosis of human long-term carriers and the develop-
ment of antigen-specific vaccines.
A second explanation for hyperresponsiveness to Babesia infection
in SS mice is that these mice may have a very sensitive immune
system, enabling them to respond strongly to even very low levels of
parasitemia via an enhanced recognition of parasites. This can be
explained if SCD mice are resistant to the Babesia infection but
respond very strongly to low levels of parasitemia. SCD mice have a
substantial increase in the levels of reticulocytes, immature RBCs,
relative to mature RBCs, ;40% to 80% compared with 4% in AA
mice.56 It has been shown that Babesia multiply better in mature
RBCs than in reticulocytes, shown by the differences in the
percentages of intracellular parasites. For example, ,10% of
reticulocytes contain intracellular parasites at any point of the
infection whereas .70% of mature RBCs contain parasites on day
3
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Figure 7. Analysis of B microti–specific IgG responses.
Plasma was collected from mice on day10 (A) and day 17 (B) in
Townes (AA, AS, SS) mice following B microti infection and the
levels of Babesia-specific IgG antibody were determined by ELISA
using recombinant B microti proteins as listed in supplemental
Table 1 (n 5 2-3). Error bars indicate the mean 6 SEM. *P , .05;
**P , .01; by unpaired 2-tailed Student t test.
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7 following Babesia infection.26 As such, the overall infection rate
can be reduced in SCD, relative to AA or AS mice. If SCD mice are
equipped with a very sensitive immune recognition system for
detecting Babesia, they can induce similar levels of GC/TFH cells
in SS mice in response to low levels of parasitemia. Possible
mechanisms include an increase in the sensitivity of TCR to antigen
recognition or an increase in the antigen-presenting function. This is a
feasible possibility because SCD mice are in a chronic inflammatory
state, which can serve as the underlying mechanisms to sensitize the
inflammation. These data warrant future studies on the potential
importance of a memory response to Babesia. In particular, it
would be valuable to see whether SCD mice respond better in the
subsequent infection because they have a different repertoire of
antibodies in the primary infection.
In summary, we report in this study a thorough and quantitative
kinetics of adaptive immune response to Babesia infection. Our
unexpected finding that SCD mice mount an equally robust
adaptive immunity despite low parasitemia underscores the importance
of examining both the fate of B microti and the immunological
consequences of parasite infection in individuals with SCD to establish
whether a similar hyperimmune response against the parasite occurs
in humans too. Patients with SCD require transfusions, with some on
chronic transfusion therapy, placing them at greater risk of acquiring
transfusion-transmitted infections like babesiosis as currently there is
no mandate to screen blood for this blood-borne pathogen. As
such, these individuals, if transfused from an infected donor, would
be exposed to a larger infectious dose compared with a tick bite.
Furthermore, chronically transfused patients would be at higher risk
of reinfection via transfusion. The outcome of these infections,
whether one of immune protection mediated by the first infection or
a more deleterious pathological sequel, is required to be studied to
establish effective treatments for these patients.
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